Bharat Biotech's MD's Reply To Those Who Questioned Covaxin's Efficacy

The chairman of Bharat Biotech - whose coronavirus vaccine Covaxin has been given "restricted use in emergency situation in public interest" - hit out Monday at critics flagging the lack of Phase III trial data. Addressing a virtual presser this evening Dr Ella said his company had carried out "200 per cent honest clinical trials", had an established track record in producing 16 safe and efficacious vaccines, and was transparent with all data.